150 related articles for article (PubMed ID: 35680695)
1. Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data.
De Leo A; Vara G; Paccapelo A; Balacchi C; Vicennati V; Tucci L; Pagotto U; Selva S; Ricci C; Alberici L; Minni F; Nanni C; Ambrosi F; Santini D; Golfieri R; Di Dalmazi G; Mosconi C
J Endocrinol Invest; 2022 Oct; 45(10):1935-1944. PubMed ID: 35680695
[TBL] [Abstract][Full Text] [Related]
2. CT Texture Analysis of Adrenal Pheochromocytomas: A Pilot Study.
Crimì F; Agostini E; Toniolo A; Torresan F; Iacobone M; Tizianel I; Scaroni C; Quaia E; Campi C; Ceccato F
Curr Oncol; 2023 Feb; 30(2):2169-2177. PubMed ID: 36826128
[TBL] [Abstract][Full Text] [Related]
3. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
[TBL] [Abstract][Full Text] [Related]
4. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma.
Koh JM; Ahn SH; Kim H; Kim BJ; Sung TY; Kim YH; Hong SJ; Song DE; Lee SH
PLoS One; 2017; 12(11):e0187398. PubMed ID: 29117221
[TBL] [Abstract][Full Text] [Related]
5. Differentiating pheochromocytoma from lipid-poor adrenocortical adenoma by CT texture analysis: feasibility study.
Zhang GM; Shi B; Sun H; Jin ZY; Xue HD
Abdom Radiol (NY); 2017 Sep; 42(9):2305-2313. PubMed ID: 28357529
[TBL] [Abstract][Full Text] [Related]
6. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract][Full Text] [Related]
7. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
Sane T; Schalin-Jäntti C; Raade M
J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
[TBL] [Abstract][Full Text] [Related]
8. Locally invasive recurrence or metastasis of pheochromocytoma into the liver?-clinicopathological challenges.
Tang SS; Lee JWK; Wijerethne S; Iyer SG; Hue S; En NM; Parameswaran R
World J Surg Oncol; 2022 Nov; 20(1):360. PubMed ID: 36368995
[TBL] [Abstract][Full Text] [Related]
9. Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma.
Gao X; Yamazaki Y; Pecori A; Tezuka Y; Ono Y; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587779. PubMed ID: 33244312
[TBL] [Abstract][Full Text] [Related]
10. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
11. Adrenal and extra-adrenal nonfunctioning composite pheochromocytoma/paraganglioma with immunohistochemical ectopic hormone expression: comparison of two cases.
Gong J; Wang X; Chen X; Chen N; Huang R; Lu C; Chen D; Zeng H; Zhou Q
Urol Int; 2010; 85(3):368-72. PubMed ID: 20829582
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.
Thompson LD
Am J Surg Pathol; 2002 May; 26(5):551-66. PubMed ID: 11979086
[TBL] [Abstract][Full Text] [Related]
13. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G
Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014
[TBL] [Abstract][Full Text] [Related]
14. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
15. Adrenal tracer uptake by
Noordzij W; Glaudemans AWJM; Schaafsma M; van der Horst-Schrivers ANA; Slart RHJA; van Beek AP; Kerstens MN
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1560-1566. PubMed ID: 31011769
[TBL] [Abstract][Full Text] [Related]
16. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?
Patel J; Davenport MS; Cohan RH; Caoili EM
AJR Am J Roentgenol; 2013 Jul; 201(1):122-7. PubMed ID: 23789665
[TBL] [Abstract][Full Text] [Related]
17. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma.
Blake MA; Krishnamoorthy SK; Boland GW; Sweeney AT; Pitman MB; Harisinghani M; Mueller PR; Hahn PF
AJR Am J Roentgenol; 2003 Dec; 181(6):1663-8. PubMed ID: 14627592
[TBL] [Abstract][Full Text] [Related]
18. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
19. MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?
Northcutt BG; Raman SP; Long C; Oshmyansky AR; Siegelman SS; Fishman EK; Johnson PT
AJR Am J Roentgenol; 2013 Oct; 201(4):834-9. PubMed ID: 24059372
[TBL] [Abstract][Full Text] [Related]
20. 15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma.
Tischler AS; deKrijger RR
Endocr Relat Cancer; 2015 Aug; 22(4):T123-33. PubMed ID: 26136457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
